IP Verse

Ophthalmological Composition

Patent No. EP3426226 (titled "Ophthalmological Composition") was filed by Ursapharm Arzneimittel on Mar 7, 2017. The application was issued on May 4, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BITOPFeb 3, 2023HEIDE
BAUSCH LOMB IRELANDFeb 2, 2023MAIWALD
PHARMA STULLNJun 9, 2022GREINER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3426226

URSAPHARM ARZNEIMITTEL
Application Number
EP17709641A
Filing Date
Mar 7, 2017
Status
Revoked
Aug 30, 2024
Publication Date
May 4, 2022
External Links
Slate, Register , Google Patents